Antimetabolites: all 7,479 studies that test it
Page 61 of 75. Open to participants first (1,134), then studies with results posted, then the rest; newest registration first within each.
- Study of Weekly DCF to Treat Advanced Gastric CancerTerminatedNCT00568971Phase 2
- Combination of Capecitabine and Oxaliplatin in Patients With Relapsed or Refractory Gastric CancerSuspendedNCT00568529Phase 2
- Trial Comparing Chlorambucil to Fludarabine in Patients With Advanced Waldenström MacroglobulinemiaCompletedNCT00566332Phase 3
- A Pilot Trial With Subcutaneous Alemtuzumab and Oral Fludarabinephosphate for the Determination of Safety, Efficacy and Molecular Profiling for the Prediction of ResponseCompletedNCT00565981Phase 2
- Combination Study of Capecitabine and Erlotinib Concurrent With Radiotherapy for Non-Operable Advanced Pancreatic CancerCompletedNCT00565487Phase 1
- Fludarabine, Cyclophosphamide, and Rituximab or Alemtuzumab in Treating CLL2007 CLL 2007 FMPCompletedNCT00564512Phase 3
- Leflunomide + Methotrexate in Rheumatoid ArthritisCompletedNCT00563849Phase 4
- Study of Efficacy of Induction Chemotherapy With Gemcitabine and Carboplatin for Operable Non-small-cell Lung Cancer Before SurgeryStatus unknownNCT00563160Phase 2
- Capecitabine to Prevent Recurrence of Hepatocellular Carcinoma After Curative ResectionStatus unknownNCT00561522Phase 2/3
- Maintenance Versus Observation After 6 Cycles of Gemcitabine Plus Paclitaxel in Pts With Advanced Breast CancerCompletedNCT00561119Phase 3
- Efficacy of Allopurinol and Dypiridamole in Acute ManiaCompletedNCT00560079Phase 4
- Safety and Tolerability Open Label Dose Escalation Study of Acadesine in B-CLL PatientsCompletedNCT00559624Phase 1/2
- Phase II Study of Eloxatin+5-FU/LV in Patients With Unresectable Hepatocellular CarcinomaCompletedNCT00559455Phase 2
- Safety Study of Oxaliplatin and 5-fluorouracil Followed by FUDR for Unresectable Colorectal Liver MetastasesCompletedNCT00557557Phase 1
- Gemcitabine, Cisplatin, and Radiation Therapy in Treating Patients With Stage II or Stage III Bladder CancerCompletedNCT00556621Phase 1/2
- Study of Pralatrexate in Patients With Relapsed or Refractory Cutaneous T-cell LymphomaCompletedNCT00554827Phase 1
- Top Down Versus Step Up Strategies in Crohn's DiseaseCompletedNCT00554710Phase 4
- A Phase II Study of the Association of Glivec® Plus Gemzar® in Patients With Unresectable, Refractory, Malignant MesotheliomaStatus unknownNCT00551252Phase 2
- Gemcitabine, Paclitaxel, Ifosfamide, and Cisplatin in Treating Patients With Progressive or Relapsed Metastatic Germ Cell TumorsStatus unknownNCT00551122Phase 1/2
- Gemcitabine/Capecitabine/ZD6474 in Advanced Solid TumorsCompletedNCT00551096Phase 1
- LBH589 and Gemcitabine in the Treatment of Solid TumorsTerminatedNCT00550199Phase 1
- Phase II Study to Evaluate Efficacy and Safety of RP101 in Combination With GemcitabineTerminatedNCT00550004Phase 2
- High-Selenium Brassica Juncea, Irinotecan, and Capecitabine in Treating Patients With Advanced CancerCompletedNCT00547547Phase 1
- Phase I/II Intratumoral DC Immunotherapy With Gemcitabine & XRT in Unresectable Pancreatic CancerCompletedNCT00547144Phase 1
- Everolimus, Cytarabine, and Daunorubicin in Treating Patients With Relapsed Acute Myeloid LeukemiaStatus unknownNCT00544999Phase 1
- Pre-operative Chemotherapy in Operable Breast Cancer, Phase III Study Comparing a Short Intensive Pre-operative Chemotherapy With the Same Therapy Initiated Shortly After Surgery(Peri-operatively)(POCOB)EORTC 10902)Status unknownNCT00544505Not applicable
- Fluorouracil, Cisplatin, Cetuximab, and Radiation Therapy in Treating Patients With Esophageal Cancer That Can Be Removed by SurgeryCompletedNCT00544362Phase 1/2
- Leucovorin, Fluorouracil, Cetuximab, and Oxaliplatin in Treating Patients With Stage IV Colorectal Cancer and Liver Metastases That Cannot Be Removed by SurgeryCompletedNCT00544349Phase 2
- Preoperative Epirubicin Paclitaxel Aranesp Study (PREPARE)CompletedNCT00544232Phase 3
- Gemcitabine and Radiation Therapy in Treating Patients With Locally Advanced Upper Gastrointestinal CancerCompletedNCT00544193Phase 1
- Bevacizumab, Erlotinib, and Capecitabine for Locally Advanced Rectal CancerCompletedNCT00543842Phase 1
- MGCD0103 Administered in Combination With Azacitidine (Vidaza®) to Subjects With Relapsed or Refractory Hodgkin or Non-Hodgkin LymphomaTerminatedNCT00543582Phase 2
- Dose Escalation Study of Revlimid With Fludarabine-Rituximab for CLL/SLLTerminatedNCT00543114Phase 1
- Radiation Therapy, Chemotherapy, and Cetuximab Followed by Surgery, Chemotherapy, and Cetuximab in Treating Patients With Locally Advanced or Metastatic Rectal Cancer That Can Be Removed by SurgeryTerminatedNCT00541112Phase 2
- Gemcitabine With or Without Sorafenib in Treating Patients With Locally Advanced or Metastatic Pancreatic CancerStatus unknownNCT00541021Phase 3
- Natural Killer Cells in Older Patients With Acute Myeloid LeukemiaCompletedNCT00540956Not applicable
- BREAST-10: Three-weekly Versus Weekly First-line Chemotherapy for Metastatic or Locally Advanced Breast CancerCompletedNCT00540800Phase 3
- Phase I Epigenetic Priming Using Decitabine With Induction Chemotherapy in AMLCompletedNCT00538876Phase 1
- Vorinostat, Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Upper Gastrointestinal CancerCompletedNCT00537121Phase 1
- A Study of Gemcitabine ± Erlotinib and DN-101 Versus Gemcitabine ± Erlotinib and Placebo in Patients With Advanced Pancreatic CancerSuspendedNCT00536770Phase 2
- Phase I Vandetanib Plus Capecitabine, Oxaliplatin and Bevacizumab for Metastatic Colorectal CancerCompletedNCT00532909Phase 1
- Phase II Study of Primary Chemotherapy With Paclitaxel, Gemcitabine, and TrastuzumabCompletedNCT00532857Phase 2
- Phase II Study of Gemcitabine/Vinorelbine vs Sequential Gemcitabine Followed by Vinorelbine in Metastatic Breast CancerCompletedNCT00532623Phase 2
- Trial of Paclitaxel, Gemcitabine and Cisplatin in Patients With Relapsing Germ Cell CancerTerminatedNCT00531687Phase 2
- Reduced Intensity AlloSCT in(CML) With Persistent DiseaseTerminatedNCT00531310Phase 2
- A Phase I/II Trial of TS-1 and Oxaliplatin in Patients With Advanced Colorectal CancerCompletedNCT00531245Phase 1/2
- Fludarabine and Cytarabine as Continuous Infusion Plus G-CSF Priming for Elderly Patients With Resistant AMLStatus unknownNCT00529880Phase 2
- Allogeneic Stem Cell Transplant With Clofarabine, Ara-C and TBI for AML and ALLCompletedNCT00529360Phase 1/2
- Azacitidine and Valproic Acid Plus Carboplatin in Patients With Ovarian CancerCompletedNCT00529022Phase 1
- Safety, Pharmacokinetics, and Pharmacodynamics of Oral Azacitidine in Subjects With Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia and Acute Myelogenous LeukemiaCompletedNCT00528983Phase 1
- A Study To Find The Best Dose Of SU011248 When Given With Pemetrexed, Pemetrexed And Cisplatin Or Pemetrexed And Carboplatin In Patients With Advanced Solid TumorsCompletedNCT00528619Phase 1
- A Phase II Trial of Lapatinib (TYKERB) + Pemetrexed (ALIMTA) in Advanced Non Small Cell Lung Cancer With an Initial Dose Finding PhaseCompletedNCT00528281Phase 1
- Phase II Trial of Oxaliplatin in Combination With S-1(SOX) in Patients With Recurrent or Metastatic Breast CancerCompletedNCT00527930Phase 2
- Investigating the Biological Effects of the Addition of Zoledronic Acid to Pre-operative Chemotherapy in Breast CancerCompletedNCT00525759Phase 2
- Phase I/II Study of SOL for Untreated Metastatic Colorectal CancerStatus unknownNCT00524706Phase 1/2
- HDAC Inhibitor Valproic Acid as an Effective Therapy for Chronic Lymphocytic LeukemiaTerminatedNCT00524667Phase 2
- Sunitinib, Irinotecan, Fluorouracil, and Leucovorin In Treating Patients With Advanced Stomach Cancer or Gastroesophageal CancerTerminatedNCT00524186Phase 1
- Gemcitabine, Capecitabine, and Bevacizumab in Treating Patients With Pancreatic Cancer That Can Be Removed By SurgeryWithdrawnNCT00524069Not applicable
- Cytochlor, Tetrahydrouridine, and External-Beam Radiation Therapy in Treating Patients With Cancer That Has Spread to the BrainCompletedNCT00521183Phase 1
- Hydroxyurea in Young Children With Sickle Cell AnemiaCompletedNCT00519701Not applicable
- Sorafenib and Low Dose Cytarabine in Older Patients With Acute Myeloid Leukemia or High-Risk Myelodysplastic SyndromeCompletedNCT00516828Phase 1/2
- Gene Expression Profiling in Patients With Invasive Bladder Cancer Receiving Methotrexate, Vinblastine, Doxorubicin, and CisplatinTerminatedNCT00516750Phase 2
- Phase II Study Evaluating Busulfan and Fludarabine as Preparative Therapy in Adults With Hematopoietic Disorders Undergoing MUD SCTCompletedNCT00516152Phase 2
- Study to Assess the Safety & Tolerability of a PARP Inhibitor in Combination With Gemcitabine in Pancreatic CancerCompletedNCT00515866Phase 1
- DepoCyt Plus Temozolomide in Patients With Neoplastic MeningitisTerminatedNCT00515788Phase 1
- Study of Continuous or Intermittent S-1 Combined With Oxaliplatin in Recurrent or Metastatic Gastric CarcinomaStatus unknownNCT00515190Phase 2
- Medical Treatment of Colitis in Patients With Hermansky-Pudlak SyndromeWithdrawnNCT00514982Phase 2
- Feasibility Study of Acute Myelogenous Leukemia mRNA Plus Lysate Loaded Dendritic Cell VaccinesTerminatedNCT00514189Phase 1
- GEM vs GEM+TS-1 for Advanced Pancreatic CancerCompletedNCT00514163Phase 2
- High-Dose Methotrexate in Treating Young Patients With Solid TumorsCompletedNCT00513981Phase 1
- PVAG-14 Pilot for Intermediate Stages Hodgkin LymphomaTerminatedNCT00512980Phase 2
- A Phase II Study of Irinotecan, Oxaliplatin, Plus TS-1 in Untreated Metastatic Gastric CancerCompletedNCT00512681Phase 2
- APEX Study: Effects of Allopurinol on Coronary and Peripheral Endothelial Function in Patients With Cardiac Syndrome XCompletedNCT00512057Phase 4
- Trial of Docetaxel, Oxaliplatin and Capecitabine (TEX) in Advanced or Metastatic Gastric CancerCompletedNCT00511446Phase 2
- Primary Breast Cancer Occurring Concomitant With PregnancyCompletedNCT00510367Early Phase 1
- Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, Leucovorin, and AvastinCompletedNCT00507585Phase 1
- Preoperative Chemoradiotherapy With Cetuximab in Rectal CancerStatus unknownNCT00506844Phase 2
- Preoperative Chemoradiotherapy With Capecitabine Plus Irinotecan in Rectal CancerStatus unknownNCT00506623Phase 2
- Phase II Study of Irinotecan,Oxaliplatin Plus TS-1 in Untreated Metastatic Colorectal CancerStatus unknownNCT00506571Phase 2
- A Phase I Study of S-1 Plus Irinotecan and Oxaliplatin in Advanced Gastrointestinal MalignancyStatus unknownNCT00506207Phase 1
- Study of Irinotecan & Capecitabine in Metastatic Colorectal CancerTerminatedNCT00506168Phase 2
- Myfortic Versus Azathioprine in Systemic Lupus ErythematosusTerminatedNCT00504244Phase 3
- A Phase II Study of Gemcitabine With Oxaliplatin as First Line Chemotherapy in Advanced Biliary Tract CancerCompletedNCT00504192Phase 2
- Proton Therapy With Capecitabine for Rectal CancerWithdrawnNCT00503932Phase 1/2
- Methotrexate and Temozolomide Versus Methotrexate, Procarbazine, Vincristine and CytarabineStatus unknownNCT00503594Phase 2
- Phase II Study of TS-1 Therapy and TS-1+PSK Therapy Against Advanced Gastric CarcinomaTerminatedNCT00503321Phase 2/3
- FOLFOX Chemotherapy Regimen (5-FU, Leucovorin, Oxaliplatin) in Metastatic Colorectal CancerCompletedNCT00501410Phase 1
- Doxil, Gemcitabine, and Velcade (PS341) in Advanced Cancer PatientsCompletedNCT00500422Phase 1
- Phase I FOLFOX CombinationCompletedNCT00499850Phase 1
- Multicentre, Dose Finding, Ph II,CP-4055 in Comb. With Sorafenib - Patients With Metastatic Malignant MelanomaCompletedNCT00498836Phase 2
- A Phase II Study of CP-4055 as Second Line Therapy in Patients With Advanced Colorectal CancerCompletedNCT00498407Phase 2
- Cord Blood Expansion on Mesenchymal Stem CellsCompletedNCT00498316Phase 1
- Phase III of Gemcitabine Vs TS-1 Vs Gemcitabine Plus TS-1 in Pancreatic CancerCompletedNCT00498225Phase 3
- Gemcitabine, Capecitabine, and Oxaliplatin as Second-Line Therapy in Treating Patients With Advanced Colorectal Cancer Previously Treated With IrinotecanStatus unknownNCT00496704Phase 1/2
- Azacytidine and Valproic Acid in Patients With Advanced CancersCompletedNCT00496444Phase 1
- Clinical Trial on the Mixture of G, C and S in Treatment of Patients With RCCCompletedNCT00496301Phase 2
- Phase I Combination With Vinorelbine or Gemcitabine Plus Cisplatin in Locally Advanced or Metastatic NSCLCCompletedNCT00496275Phase 1
- SIMIDIS: Azacitidine and Beta Erythropoietin Treatment in Patients With Myelodysplastic SyndromeTerminatedNCT00495547Phase 2
- A Remission Induction Therapy and Risk-oriented Postremission Strategy for Adult Acute Myelogenous Leukemia (AML)CompletedNCT00495287Phase 3
- MMF vs. AZA for Kidney TransplantationCompletedNCT00494741Phase 4